BROOKHAVEN, Miss. (AP) — Willie Cory Godbolt, the man accused of killing a sheriff's deputy and seven people he knew in rural Mississippi, has led a life marked by violence, starting with his own parents.

By Lisa Rapaport (Reuters Health) – - Every eight minutes in the U.S., a child under three has an accident related to baby products like strollers, carriers, cribs and walkers, a study suggests. Injuries are on the rise, and roughly four in five are due to falls, researchers report in Pediatrics. “What’s surprising is how many children are still experiencing nursery product-related injuries serious enough to result in a trip to the emergency department – one every eight minutes,” said senior study author Dr. Gary Smith, director of the Center for Injury Research and Policy at Nationwide Children’s Hospital in Columbus, Ohio.

WEDNESDAY, Feb. 17, 2016 (HealthDay News) — Women with early stage breast cancer who opt for a breast-conserving surgery known as a lumpectomy have a one in four chance they will need a second operation within 90 days, researchers report.

“The chance of getting a second surgery has gone down a little, but it is still high and it is substantial,” said study author Dr. Art Sedrakyan. He is a professor of health care policy and research at Weill Cornell Medical Center in New York City.

In a lumpectomy, the tumor tissue, along with a margin of surrounding tumor-free tissue, is removed. However, if the tissue in the margin is not completely free of tumor cells, a second operation is needed.

During the study period, which ran from 2003 through 2013, the overall rate of re-operation within 90 days was almost 31 percent, Sedrakyan said. It declined from nearly 40 percent in 2003 through 2004, to 23 percent from 2011 through 2013, the study found.

“Having a second surgery after you think you’ve solved all your problems is stressful,” Sedrakyan said.

The question of how often women need a repeat surgery is critical for a number of reasons, Sedrakyan explained. These reasons include letting women know the risk of re-operation if they choose breast-conservation surgery. Doctors also need to know the risk so they can come up with guidance to help reduce that risk, he said.

“Patients operated on by higher-volume doctors had a lower chance of getting this re-operation,” Sedrakyan said. High-volume surgeons were defined as those who had 34 or more cases a year, on average, while low-volume surgeons had 13 or fewer cases. The lowered risk with high-volume doctors was about 33 percent, the study findings showed.

The study appears in the Feb. 17 online edition in the journal JAMA Surgery.

The researchers evaluated data on nearly 90,000 women who had lumpectomies in hospitals and ambulatory surgery centers in New York. The rates of re-operation were highest among those aged 20 to 49 and lowest in those aged 65 and older.

“We need to make sure women know about this risk, and are making informed decisions,” Sedrakyan said. He believes the data, while gathered only from one state, New York, would be applicable to other regions of the United States.

The decline found in re-operation rates in the study is probably due to a number of factors, Echo said. They include better training of breast surgeons and the team approach now used at many hospitals.

“There is much more knowledge,” Echo said. And some radiologists and pathologists now dedicate their practices to breast cancer, he added.

The team approach may indeed help explain the decline, along with better techniques, Sedrakyan said. In addition, new guidelines from the Society of Surgical Oncology and the American Society for Radiation Oncology specifying when re-operation is needed may further reduce the second surgery rates, the study authors suggested.

TUESDAY, Aug. 2, 2016 (HealthDay News) — Insurance coverage and the distance to a doctor’s office affect the likelihood that breast cancer patients will have reconstructive surgery after breast removal, a new study finds.

Researchers analyzed data from nearly 5,400 women in North Carolina who were diagnosed with breast cancer between 2003 and 2006 and had breast removal (mastectomy) within six months of diagnosis.

Twenty percent had breast reconstruction surgery within two years.

Compared to patients with private insurance, those with Medicare coverage were 42 percent less likely to have breast reconstruction and those with Medicaid coverage were 76 percent less likely. Medicare and Medicaid are U.S. government health insurance programs.

The University of North Carolina researchers also found that compared to women who lived within 10 miles of a plastic surgeon’s office, those who lived 10 to 20 miles away were 22 percent less likely to have the surgery, and those who lived 20 or more miles away were 27 percent less likely.

Minority patients were 50 percent less likely than whites to undergo breast reconstruction, according to the study published in the August issue of the journal Plastic and Reconstructive Surgery.

As in previous research, this study found that older age, advanced cancer and radiation treatment were associated with a lower likelihood of breast reconstruction surgery.

“We know that breast cancer affects not only the physical well-being of the patient, but also her psychosocial well-being, and we know that breast reconstruction can help address those issues,” study first author Dr. Michelle Roughton said in a university news release.

“These findings highlight the fact that there are more barriers to breast reconstruction access than we previously recognized,” she said.

Roughton is an assistant professor of surgery and program director of the Division of Plastic and Reconstructive Surgery at the university’s School of Medicine.

Many women may only need a mammogram once every three years, according to a new study, instead of the current government recommendation of every two years. The findings apply to a large percentage of women ages 50 to 74 who have lower breast density and average breast cancer risk. On the other hand, the study found, those with high breast density may be better off with more screenings—one every year.

The findings, published Monday in the Annals of Internal Medicine and sponsored by the National Cancer Institute, are simply a suggestion, says the author of an editorial published along with the study. They’re not meant to replace existing guidelines put out earlier this year by the U.S. Preventive Services Task Force (USPSTF), according to Christine Berg, MD, a radiation oncologist with Johns Hopkins Medicine in Bethesda, Maryland.

The current recommendations do advocate that women and their doctors take into account their individual preferences and risk factors when considering how often they should get mammograms, the study authors point out. But, there isn’t a lot of data to help people decide what, exactly, that means.

One known risk factor for breast cancer is having dense breasts, especially after menopause. So to see if women with dense breasts and women with fatty (also known as lower density) breasts might need different advice, the researchers, led by Amy Trentham-Dietz, PhD, of the University of Wisconsin–Madison in Wisconsin and Karla Kerlikowske, MD, of the University of California, San Francisco, used computer models to evaluate the risks and benefits of various screening schedules.

They found that in both cases, every-other-year screenings for women 50 to 74 may not be the best option. According to their models, average-risk women with lower breast density can limit their mammograms to once every three years without putting themselves at increased risk. Less frequent mammograms could also reduce false-positives and unnecessary biopsies, they write.

For women with high density breasts, the researchers found the opposite: Because this group is at higher risk of cancer, they found that more frequent screenings—once a year—could potentially save lives.

Dr. Berg, who wrote the accompanying editorial, agrees that tailoring screening recommendations to different groups of people is important.

“As we make this move toward precision medicine, we are getting away from the one-size-fits-all model to a more nuanced approach,” she says. “We’re taking into account a woman’s own feelings about mammography and her own risk factors, and that’s a good thing.”

Women should consider their breast density—along with other known risk factors, such as their family history, the age of their first period, and the age at which they first had children—when they decide how often they should be screened for breast cancer, says Dr. Berg. (Dense breasts must be diagnosed by a radiologist via a mammogram; it’s not something you can tell by feel or size.) Having your period earlier in life is linked to a higher risk of breast cancer, as is having children later in life or not at all.

For women with dense breasts, she says the study’s suggestion for annual screenings “makes perfect sense.” However, she doesn’t recommend average-risk women switch to less frequent screenings until more research is done.

“If a woman has low breast density, I’d say stick with the current recommendation of every other year,” she says. “Then maybe as she gets older, as we get more data and we learn more, perhaps you could switch to every third year.”

Earlier this year, the USPSTF issued an "I" statement, which is a call for more research, about whether additional screenings might be helpful for women with dense breasts. (The evidence so far, it said, was unclear.) The group generally does not comment on individual studies such as this one, and referred Health.com to its Frequently Asked Questions page for more information on its current position.

“The Task Force hopes that in the future, there will be more evidence available to make a more definitive recommendation,” the website states. “Women with dense breasts should talk with their doctors to determine what is best for their individual health needs.”

By Kerry Grens NEW YORK (Reuters Health) – Herbal supplements aimed at improving men’s sexual abilities often contain the active ingredients in erectile dysfunction pills such as Viagra, according to a new study. Additionally, researchers found that some of these over-the-counter herbal remedies contained more of the ingredient than is allowed in prescription-only pharmaceuticals. “It’s pretty scary stuff,” said Neil Campbell, the lead author of the study and a researcher at Pfizer, which sells Viagra. “These products are not herbal at all, they’re adulterated.” The U.S. …Sexual Health News Headlines – Yahoo! News